IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed

Name: IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed
License: Public Domain

Fortvita Biologics (USA)Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

io resistant sqnsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172289
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.